Informations générales (source: ClinicalTrials.gov)
Real Life Prospective Multicentric Study Evaluating the Clinical and Organisational Impact of Moovcare® Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNG (REAL-MOOV-LUNG)
Interventional
N/A
Institut Curie (Voir sur ClinicalTrials)
octobre 2021
octobre 2026
29 juin 2024
Evaluation of patient's proportion, whose management care has been modified at least once
and specially by Moovcare® Lung application at 12 and 24 months.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT CURIE | 04/09/2024 13:49:43 | Contacter | |||
| CLCC RENE HUGUENIN INSTITUT CURIE | 04/09/2024 13:49:29 | Contacter | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| AP-HM La Timone - 13915 - Marseille - France | Laurent GREILLIER, PH | Contact (sur clinicalTrials) | |||
| Centre Hospitalier Public du Cotentin - 50100 - Cherbourg - France | Laure KALUZINSKI, MD | Contact (sur clinicalTrials) | |||
| Centre Oscar Lambret - 59000 - Lille - France | Eric DANSIN, MD | Contact (sur clinicalTrials) | |||
| CH Annecy Genevois - 74374 - Pringy - France | Contact (sur clinicalTrials) | ||||
| Chu Argenteuil - 95100 - Argenteuil - France | Laure BELMONT, MD | Contact (sur clinicalTrials) | |||
| CHU de PAU - 64046 - PAU - France | Patrick Aldo RERNAULT, MD | Contact (sur clinicalTrials) | |||
| Clinique mutualiste de l'ESTUAIRE - 44600 - Saint Nazaire - France | Thierry CHATELLIER, MD | Contact (sur clinicalTrials) | |||
| Clinique Saint-George - 06100 - Nice - France | Ophélie CASSUTO, MD | Contact (sur clinicalTrials) | |||
| Hôpital Forcilles - 77150 - Férolles Attilly - France | Salima KALLA, MD | Contact (sur clinicalTrials) | |||
| Hopital Franco Britannique - 92300 - Levallois-Perret - France | Nathalie PEREZ-STAUB | Contact (sur clinicalTrials) | |||
| Hôpital Nord-Ouest - 69400 - Gleize - France | Luc ODIER, MD | Contact (sur clinicalTrials) | |||
| Hopital Robert Schumann - 57070 - Vantoux - France | Benoit BODBERT, MD | Contact (sur clinicalTrials) | |||
| Ico Angers - 44805 - Angers - France | Contact (sur clinicalTrials) | ||||
| Nouvel Hôpital Civil - 67091 - Strasbourg - France | Bertrand MENNECIER, MD | Contact (sur clinicalTrials) | |||
| Polyclinique de Limoges - Site de François CHENIEUX - 87039 - Limoges - France | Xavier ZASADNY, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
1. Patient with lung cancer at any diagnostic stage and histology.
2. Patient willing to use the follow-up setting with Moovcare® Lung apps.
3. Age ≥ 18 years.
4. Patient received anti-cancer treatment (surgery, chemotherapy, radiation (stereotaxy
or not) or radio-chemotherapy association ended less than 12 weeks (Cohort 1
post-treatment); or during maintenance treatment or consolidation by chemotherapy or
targeted therapy, or by immunotherapy initiated less than 12 weeks (Cohort 2 during
treatment).
5. Imaging tumor evaluation less than 12 weeks showing disease control (response or
stability according to RECIST 1.1 criteria).
6. Patient with symptomatic score on Moovcare® Lung apps less than 7.
7. Patient (or relatives) with internet access, a personnal e-mail box and a
smartphone.
8. Patient with social security affiliation.
9. Signed informed consent form.
1. Patient with lung cancer at any diagnostic stage and histology.
2. Patient willing to use the follow-up setting with Moovcare® Lung apps.
3. Age ≥ 18 years.
4. Patient received anti-cancer treatment (surgery, chemotherapy, radiation (stereotaxy
or not) or radio-chemotherapy association ended less than 12 weeks (Cohort 1
post-treatment); or during maintenance treatment or consolidation by chemotherapy or
targeted therapy, or by immunotherapy initiated less than 12 weeks (Cohort 2 during
treatment).
5. Imaging tumor evaluation less than 12 weeks showing disease control (response or
stability according to RECIST 1.1 criteria).
6. Patient with symptomatic score on Moovcare® Lung apps less than 7.
7. Patient (or relatives) with internet access, a personnal e-mail box and a
smartphone.
8. Patient with social security affiliation.
9. Signed informed consent form.
1. Patient with progression after the first evaluation of initial treatment.
2. Pregnancy and breast-feeding.
3. Patient under tutorship or guardianship.
4. Dementia, mental alteration or psychiatric pathology influencing patient consent
procedure and/or protocol observance and study follow-up.
5. Patient enable to protocol follow-up for psychological, social, familial or
geographical reasons.